The STAT3 inhibitor WP1066 reverses the resistance of chronic lymphocytic leukemia cells to histone deacetylase inhibitors induced by interleukin-6
Kang Lu(Tongji University), Xin Wang(Shandong Provincial Hospital), Xin Liu(Boston Children's Hospital), Peipei Li(Zhengzhou University), Lili Feng(Shandong University), Na Wang(Qingdao University), Yujie Jiang(Shandong Provincial Hospital), Na Chen(Shandong University), Mei Ding(Ontario Institute for Cancer Research), Xiangxiang Zhou(Shandong Provincial Hospital), Jie Zhang(Shandong Provincial Hospital), Xiaosheng Fang(Shandong Provincial Hospital)
Cited by 28
Related Papers
Targeting the Wnt/β-catenin signaling pathway in cancer
|Journal of Hematology & Oncology|2020|1.4k
Mesenchymal glioma stem cells are maintained by activated glycolytic metabolism involving aldehyde dehydrogenase 1A3
|Proceedings of the National Academy of Sciences|2013|644
RBM15 facilitates laryngeal squamous cell carcinoma progression by regulating TMBIM6 stability through IGF2BP3 dependent
|Journal of Experimental & Clinical Cancer Research|2021|291
Chidamide in relapsed or refractory peripheral T cell lymphoma: a multicenter real-world study in China
|Journal of Hematology & Oncology|2017|256
Genomic and Transcriptomic Characterization of Natural Killer T Cell Lymphoma
|Cancer Cell|2020|234